CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing new drugs for tuberculosis by targeting a specific enzyme involved in the bacterium's cell wall synthesis. It aims to create a high-throughput screening method to identify novel inhibitors that could lead to more effective treatments.
Tuberculosis (TB) still claims 1.8 million deaths worldwide each year, and is the leading cause of infectious disease mortality by a bacterial pathogen.
Current therapy for TB includes a combination of at least four different drugs and has a duration of at least 6 months.
There is an urgent need for novel drugs against TB, in order to fight this disease more efficiently and with shorter course treatments, therefore increasing the likelihood for their success.Here we propose to pursue a novel tar…
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
